Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Shaoshan Zhangzhu v. Arthur Lih & Life Vac — Choking Rescue Device Patent | PatSnap
Explore in Eureka
Case ID2:25-cv-02198
FiledApr 2025
ClosedDec 2025
Patent Litigation

Shaoshan Zhangzhu v. Life Vac: Choking Rescue Device Suit Dismissed With Prejudice

Seven Chinese trading companies filed an infringement action against Arthur Lih and Life Vac LLC in the Eastern District of New York over US10025115B2, a patent covering a choking rescue device. The parties jointly stipulated to dismiss all claims and counterclaims with prejudice in 240 days, with each side bearing its own costs.

Resolution time
240days
240-day resolution — relatively swift for a multi-party E.D.N.Y. infringement action with counterclaims
Patents asserted
1
US10025115B2 — choking rescue device; airway-clearance apparatus patent
Outcome
Case Dismissed
Dismissed with prejudice on the merits by stipulation; no re-filing permitted
Cost ruling
Each Party Bears Own Costs
No fee-shifting; all attorneys’ fees, costs, and expenses borne by each party respectively
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Seven plaintiffs, one device, one stipulated exit — with prejudice

Filed on 21 April 2025 in the U.S. District Court for the Eastern District of New York, this infringement action pitted seven Chinese trading companies — led by Shaoshan Zhangzhu Trading Co., Ltd. — against Arthur Lih and Life Vac LLC. The patent at issue, US10025115B2, protects a choking rescue device, placing it squarely in the emergency airway-clearance product market where Life Vac has established commercial presence.

The case closed on 17 December 2025 via a stipulated dismissal under Fed. R. Civ. P. 41(a)(1)(A)(ii). Critically, the stipulation specifies dismissal ‘with prejudice and on the merits,’ meaning all claims — including the defendants’ counterclaims — are permanently extinguished. Neither side may relitigate these specific claims. Cost neutrality was agreed, with each party absorbing its own attorneys’ fees and litigation expenses.

The 240-day lifecycle is notable for a case involving seven named plaintiffs, bilateral counterclaims, and two defence law firms. The swift resolution — without reaching trial or summary judgment — suggests the parties may have reached a private commercial understanding, though the public record is silent on any licensing terms or financial consideration. The with-prejudice dismissal on the merits raises the bar for any future patent assertion by these plaintiffs against Life Vac on this patent.

Case at a glance
Case no.2:25-cv-02198
DefendantArthur Lih
CourtNew York Eastern
JudgeN/A
FiledApril 21, 2025
ClosedDecember 17, 2025
Duration240 days
OutcomeCase Dismissed
Verdict causeInfringement Action
BasisCase Dismissed
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / New York Eastern District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Case Dismissed in 240 days

240-day resolution — relatively swift for a multi-party E.D.N.Y. infringement action with counterclaims

Case timeline: Complaint filed APR 21 2025, AUG–SEP — 240 days total Horizontal timeline showing the three key events in Shaoshan Zhangzhu Trading Co., Ltd. v Arthur Lih from filing to resolution. Source: PACER, New York Eastern District Court. APR 21 2025 Complaint filed Pre-trial proceedings DEC 17 2025 Case Dismissed 240 DAYS TOTAL
Dismissal terms

Dismissed with prejudice: what the stipulated exit means for both sides

Legal mechanism

Rule 41(a)(1)(A)(ii) — joint stipulation, permanent bar

A Fed. R. Civ. P. 41(a)(1)(A)(ii) stipulated dismissal requires consent of all parties who have appeared. By specifying ‘with prejudice and on the merits,’ the parties went beyond a standard no-fault exit — they expressly invoked res judicata effect. All claims, counterclaims, and crossclaims are permanently resolved. No court order was required; the stipulation itself operates as a final judgment.

Res judicata applies
Plaintiff outcome

Plaintiffs close the action — future assertion on this patent is blocked

By agreeing to dismiss with prejudice, the seven plaintiff trading companies permanently relinquish their right to reassert the same infringement claims against Lih and Life Vac under US10025115B2. If any commercial resolution was reached privately, it is not visible on the public record. The cost-neutral structure suggests neither side extracted a clear financial victory in the litigation itself.

Cannot re-file these claims
Defendant outcome

Life Vac’s counterclaims also dismissed — bilateral finality

The dismissal is explicitly bilateral: defendants’ counterclaims are equally extinguished with prejudice. Life Vac and Arthur Lih cannot revive those counterclaims in future proceedings. This symmetry is consistent with a negotiated resolution where both sides agreed to a clean slate, though the precise commercial terms — if any — remain confidential.

Counterclaims also extinguished
Commercial implications

Choking rescue device IP landscape: Life Vac retains operating freedom

With the infringement action permanently closed and no injunctive relief recorded, Life Vac continues to operate in the choking rescue device market. The with-prejudice dismissal effectively ends this specific patent challenge from these plaintiffs. Competitors and product teams in the airway-clearance device space should monitor US10025115B2’s status and any related continuation patents, as the underlying IP dispute may signal contested ownership or design-around activity.

Life Vac’s market position intact
Legal analysis based on PACER docket records for case 2:25-cv-02198 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffShaoshan Zhangzhu Trading Co., Ltd.CompanyGroup of seven Chinese trading companies — holders of US10025115B2 choking rescue device patentSearch in Eureka ↗
DefendantArthur LihIndividualArthur Lih and Life Vac LLC — U.S.-based manufacturer and marketer of choking rescue devicesSearch in Eureka ↗
Plaintiff counselTao LiuAttorneyCounsel for Shaoshan Zhangzhu Trading Co., Ltd.Search in Eureka ↗
Plaintiff counselWei WangAttorneyCounsel for Shaoshan Zhangzhu Trading Co., Ltd.Search in Eureka ↗
Plaintiff law firmGlacier Law LLPLaw FirmRepresenting Shaoshan Zhangzhu Trading Co., Ltd.Search in Eureka ↗
Defendant counselMarylee JenkinsAttorneyCounsel for Arthur LihSearch in Eureka ↗
Defendant counselPeter T. BuschAttorneyCounsel for Arthur LihSearch in Eureka ↗
Defendant counselTaniel E. AndersonAttorneyCounsel for Arthur LihSearch in Eureka ↗
Defendant law firmArent Fox LLPLaw FirmRepresenting Arthur LihSearch in Eureka ↗
Defendant law firmArentFox Schiff LLPLaw FirmRepresenting Arthur LihSearch in Eureka ↗
Presiding judgeJudge N/AJudgeNew York Eastern District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“IT IS HEREBY STIPULATED AND AGREED by and between Plaintiffs Shaoshan Zhangzhu Trading Co., Ltd.; Wenxi Lixinhui Trading Co., Ltd.; Changsha Tanxiang Trading Co., Ltd.; Xiangtan Xingyan Trading Co., Ltd.; Boai County Wenkang Department Store Online Shop; Xiangxiang Junkoujin Trading Co., Ltd.; Xianyou County Huanke Trading Co., Ltd. (collectively, “Plaintiffs” or “Counterclaim Defendants”), and Defendants, Arthur Lih, and Life Vac LLC (collectively, “Defendants” or “Counterclaim Plaintiffs”), by and through their undersigned counsel of record, pursuant to Fed. R. Civ. P. 41(a)(1)(A)(ii), that all claims, counterclaims, crossclaims, and causes of action asserted in this action, including but not limited to all claims for relief set forth in the Complaint and all counterclaims set forth in Defendants’ Answer and Counterclaims, are hereby dismissed with prejudice and on the merits, with each party to bear its own costs, attorneys’ fees, and expenses incurred in connection with this action”
Source: PACER Docket, Case 2:25-cv-02198, New York Eastern District Court

The stipulation’s language — ‘dismissed with prejudice and on the merits’ — is deliberately stronger than a standard voluntary dismissal. By invoking both ‘with prejudice’ and ‘on the merits,’ the parties ensured res judicata effect, foreclosing any future attempt to relitigate these claims between these parties. The mutual dismissal of counterclaims on identical terms imposes symmetric finality, which is consistent with a negotiated resolution rather than a unilateral concession by either side.

PACER case 2:25-cv-02198 · Public docket record Explore in Eureka ↗
Patent at issue

US10025115B2 — Choking Rescue Device Patent

Publication No.US10025115B2
Application No.US15/359476
Patent details
ProductAirway-clearance choking rescue device apparatus
Cited in actionApril 21, 2025

US10025115B2, filed under application number US15/359476, protects a choking rescue device — an apparatus designed to clear airway obstructions. The patent falls within the medical device and emergency response equipment domain. Its assertion by a group of Chinese trading companies against Life Vac, a U.S. commercial player, suggests the patent covers design or functional elements that overlap with Life Vac’s product line in the consumer and clinical choking-relief segment.

Life Vac has established brand recognition in the anti-choking device market, making US10025115B2 strategically significant. A valid, enforceable patent in this space can affect product design, distribution agreements, and market entry for competitors. The contested nature of this action — which generated counterclaims before resolving — suggests Life Vac disputed at least some of the patent’s scope or validity, though no court ruling on those merits was issued.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO against US10025115B2?

Any company designing, manufacturing, importing, or distributing choking rescue or anti-choking devices in the U.S. market should treat US10025115B2 as an active clearance risk. The with-prejudice dismissal in this case only bars these specific plaintiffs from suing Life Vac — it provides no protection to other market participants. New entrants and existing competitors in the airway-clearance device segment should confirm whether their product architectures fall outside the patent’s claims.

PatSnap Eureka’s FTO Search Agent can map the full claim scope of US10025115B2, identify related family members and continuation applications, and flag design-around opportunities. For supply-chain teams sourcing anti-choking devices from Chinese manufacturers, Eureka can also surface whether upstream suppliers hold, license, or have assigned rights in this patent — critical context before any commercial commitment is made.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US10025115B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar patent cases: choking rescue device and airway-clearance device IP in U.S. courts

Cases involving anti-choking and airway-clearance device patents litigated in U.S. district courts, including the Eastern District of New York.

🔍
Access 40+ similar cases in PatSnap Eureka
Shaoshan Zhangzhu Trading Co., Ltd. patent enforcement history, New York Eastern case history, Shaoshan Zhangzhu Trading Co., Ltd.’s full IP portfolio, and comparable case analysis
Life Vac prior litigationE.D.N.Y. device IP casesAirway-clearance patent suitsChinese plaintiff enforcement trends
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the choking rescue device IP landscape

A swift with-prejudice exit in a seven-plaintiff patent action typically signals private resolution. Here is what product and IP teams should note.

With-prejudice exits raise the res judicata shield for defendants

Life Vac secured a with-prejudice dismissal, meaning the seven plaintiff companies cannot reassert US10025115B2 against it. For IP teams tracking this space, that creates a meaningful enforcement gap — but only for this defendant group. Third parties holding the same patent rights face no such bar.

Cost neutrality in multi-plaintiff cases often indicates private settlement consideration

When litigation involving seven plaintiffs, two defence firms, and bilateral counterclaims resolves with ‘each party bears its own costs,’ it typically suggests the economic terms were agreed privately. Public records disclose no royalty, licence, or damages payment — due diligence should treat underlying terms as unknown.

🔒
Full strategic analysis in PatSnap Eureka
Unlock gated insights on US10025115B2 patent family risk and enforcement patterns in the E.D.N.Y. choking rescue device litigation landscape.
Patent family risk mapSupply-chain IP exposurePlaintiff entity structure
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Shaoshan v Arthur — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Monitor anti-choking device patent risk before your next product launch

US10025115B2 remains a live IP asset in a commercially active product segment. Use PatSnap Eureka to run a targeted FTO, map the full patent family, and track enforcement activity before entering the choking rescue device market.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.